This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1998 Feb 4;90(3):182-3.

doi: 10.1093/jnci/90.3.182.

Cognitive dysfunction following adjuvant treatment of breast cancer: a new dose-limiting toxic effect?

P A Ganz

PMID: 9462670
DOI: 10.1093/jnci/90.3.182

Editorial

Cognitive dysfunction following adjuvant treatment of breast cancer: a new dose-limiting toxic effect?

P A Ganz. J Natl Cancer Inst. 1998.

. 1998 Feb 4;90(3):182-3.

doi: 10.1093/jnci/90.3.182.

Author

P A Ganz

PMID: 9462670
DOI: 10.1093/jnci/90.3.182

No abstract available

PubMed Disclaimer

Comment on

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.
van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, Rodenhuis S. van Dam FS, et al. J Natl Cancer Inst. 1998 Feb 4;90(3):210-8. doi: 10.1093/jnci/90.3.210. J Natl Cancer Inst. 1998. PMID: 9462678 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Medical
- MedlinePlus Health Information